Institute for Cell and Tumor Biology

About the Schneider Lab

Welcome to the Schneider Lab, a vibrant hub of scientific inquiry and innovation nestled within the Department of Developmental Biology at Erasmus MC, Rotterdam, and the Institute for Cell and Tumor Biology, Uniklinik RWTH Aachen. Visit our dedicated portal at to learn more about our exciting work.

At the Schneider Lab, we are driven by a profound commitment to understanding and combating clonal myeloid neoplasms. Through a multidisciplinary approach that spans genomics, proteomics, CRISPR Cas9 gene editing, and advanced 3D cell-culture modeling, our research delves into the complex regulation of hematopoietic stem cells in myeloid malignancies. Our mission is clear: to identify and validate novel therapeutic targets capable of eradicating disease-initiating cells and transforming patient outcomes.

Our team thrives in an open, friendly, and diverse international environment, fostering collaboration across borders and disciplines. We utilize cutting-edge technologies, including various single-cell genomic tools and transgenic mouse models, to unravel the cellular and molecular mechanisms underpinning disease. This concerted effort enables us to explore innovative treatment strategies and bring forth groundbreaking discoveries, such as our work on the cellular drivers of bone marrow fibrosis and the regulation of hematopoietic stem cells in del(5q) MDS.


Univ.-Prof. Dr.
Rebekka Schneider-Kramann


Uniklinik RWTH Aachen
Pauwelsstrasse 30
D-52074 Aachen

Eveline Mierau
+49 241 80-80760 (Büro)
+49 241 80-80759 (Sekretariat)
Fax: +49 241 80-82008
Standort: Uniklinik RWTH Aachen, Etage -1, D1-D2, Raum 5